← Back to Search
N-Arylmethyl Substituted Iminoribitol Derivatives As Inhibitors Of A Purine Specific Nucleoside Hydrolase.
A. Goeminne, M. Berg, M. Mcnaughton, G. Bal, G. Surpateanu, P. Van der Veken, S. De Prol, W. Versées, J. Steyaert, Achiel Haemers, K. Augustyns
Published 2008 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
A key enzyme within the purine salvage pathway of parasites, nucleoside hydrolase, is proposed as a good target for new antiparasitic drugs. We have developed N-arylmethyl-iminoribitol derivatives as a novel class of inhibitors against a purine specific nucleoside hydrolase from Trypanosoma vivax. Several of our inhibitors exhibited low nanomolar activity, with 1,4-dideoxy-1,4-imino-N-(8-quinolinyl)methyl-d-ribitol (UAMC-00115, K(i) 10.8nM), N-(9-deaza-adenin-9-yl)methyl-1,4-dideoxy-1,4-imino-d-ribitol (K(i) 4.1nM), and N-(9-deazahypoxanthin-9-yl)methyl-1,4-dideoxy-1,4-imino-d-ribitol (K(i) 4.4nM) being the three most active compounds. Docking studies of the most active inhibitors revealed several important interactions with the enzyme. Among these interactions are aromatic stacking of the nucleobase mimic with two Trp-residues, and hydrogen bonds between the hydroxyl groups of the inhibitors and amino acid residues in the active site. During the course of these docking studies we also identified a strong interaction between the Asp40 residue from the enzyme and the inhibitor. This is an interaction which has not previously been considered as being important.
This paper references
Iminoribitol transition state analogue inhibitors of protozoan nucleoside hydrolases.
R. W. Miles (1999)
Weakly polar interactions in proteins.
S. Burley (1988)
Transition-state complex of the purine-specific nucleoside hydrolase of T. vivax: enzyme conformational changes and implications for catalysis.
W. Versées (2006)
Enzymatic transition states and transition state analog design.
V. Schramm (1998)
Electronic nature of the transition state for nucleoside hydrolase. A blueprint for inhibitor design.
B. Horenstein (1993)
Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors.
A. Goeminne (2008)
New insights into the mechanism of nucleoside hydrolases from the crystal structure of the Escherichia coli YbeK protein bound to the reaction product.
Laura Muzzolini (2006)
Synthesis of a transition state analogue inhibitor of purine nucleoside phosphorylase via the Mannich reaction.
G. B. Evans (2003)
Leaving group activation by aromatic stacking: an alternative to general acid catalysis.
W. Versées (2004)
Computational study of IAG-nucleoside hydrolase: determination of the preferred ground state conformation and the role of active site residues.
Devleena Mazumder-Shivakumar (2005)
Second generation transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase.
G. B. Evans (2005)
Structure and function of a novel purine specific nucleoside hydrolase from Trypanosoma vivax.
W. Versées (2001)
Enzyme-Substrate Interactions in the Purine-specific Nucleoside Hydrolase from Trypanosoma vivax*
W. Versées (2002)
Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.
G. B. Evans (2003)
1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors.
A. Goeminne (2007)
One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
R. W. Miles (1998)
A facile O-glycosidation using stannic chloride.
K. Honma (1976)
Improved Syntheses of 3H,5H-Pyrrolo[3,2-d]pyrimidines.
R. Furneaux (1999)
Transition-state analysis of nucleoside hydrolase from Crithidia fasciculata.
B. Horenstein (1991)
Potential chemotherapeutic targets in the purine metabolism of parasites.
M. H. E. Kouni (2003)
Synthesis of 3'-deoxy-3'-difluoromethyl azanucleosides from trans-4-hydroxy-l-proline.
X. Qiu (2005)
Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: convergent synthesis of the aza-C-nucleoside immucillins.
G. B. Evans (2001)
Polyhydroxylated pyrrolidines from sugar lactomes: Synthesis of 1,4-dideoxy-1,4-imino-d-glucitol from d-galactonolactone and syntheses of 1,4-dideoxy-1,4-imino-d-allitol, 1,4-dideoxy-1,4-imino-d-ribitol, and (2s,3r,4s)-3,4-dihydroxyproline from d-gulonolactone
G. Fleet (1988)
Synthesis of transition state inhibitors for N-riboside hydrolases and transferases
R. Furneaux (1997)
This paper is referenced by
Vrije Universiteit Brussel Structure and mechanism of the 6-oxopurine nucleosidase from Trypanosoma brucei
An Vandemeulebroucke (2010)
QM/MM molecular dynamics study of purine-specific nucleoside hydrolase.
Ruibo Wu (2012)
One-Pot Synthesis of Azanucleosides from Proline Derivatives -Stereoselectivity in Sequential Processes
A. Boto (2010)
Evaluation of Nucleoside Hydrolase Inhibitors for Treatment of African Trypanosomiasis
M. Berg (2010)
Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors.
W. Versées (2009)
Structural and biochemical characterization of the nucleoside hydrolase from C. elegans reveals the role of two active site cysteine residues in catalysis
R. Singh (2017)
Molecular modeling studies on nucleoside hydrolase from the biological warfare agent Brucella suis
D. T. Mancini (2012)
Evaluation of nucleoside hydrolase inhibitors for the treatment of 1 African trypanosomiasis
Maya Berg (2010)
Combined virtual screening, MMPBSA, molecular docking and dynamics studies against deadly anthrax: An in silico effort to inhibit Bacillus anthracis nucleoside hydrolase.
M. Karami (2017)
Convenient Synthesis of 1,4-Dideoxy-1,4-imino-D-ribitol from D-Ribose
M. Oba (2013)
Loop motion and base release in purine-specific nucleoside hydrolase: a molecular dynamics study.
N. Chen (2013)
An aza-nucleoside, fragment-like inhibitor of the DNA repair enzyme alkyladenine glycosylase (AAG).
Eduard Mas Claret (2020)
A divergent, short, and stereoselective approach to pyrrolidine iminosugars: synthesis of 1,4-dideoxy-1,4-imino-derivatives of d-allitol, d-ribitol, ethyl-erythritol, and (−)-2,3-trans-3-4-cis-dihydroxyproline
Sahadev S. Chirke (2015)
Design of New Chemotherapeutics Against the Deadly Anthrax Disease. Docking and Molecular Dynamics studies of Inhibitors Containing Pyrrolidine and Riboamidrazone Rings on Nucleoside Hydrolase from Bacillus anthracis
A. P. Guimarães (2011)
Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation
A. P. Guimarães (2011)
Mechanistic Insights into the Rate-Limiting Step in Purine-Specific Nucleoside Hydrolase.
N. Chen (2015)
A flexible enantioselective approach to 3,4-dihydroxyprolinol derivatives by SmI2-mediated reductive coupling of chiral nitrone with ketones/aldehydes
H. Zhang (2012)
One-Pot Conversion of Proline Derivatives into Iodinated Iminosugar-Based Nucleosides, Useful Precursors of Highly Functionalized Nucleoside Analogues
A. Boto (2010)
Structural explanation for the tunable substrate specificity of an E. coli nucleoside hydrolase: insights from molecular dynamics simulations
Stefan A. P. Lenz (2018)
Tight binding enantiomers of pre-clinical drug candidates.
G. B. Evans (2015)
A divergent approach for the synthesis of some polyhydroxy pyrrolidines and piperidines from ribosylamine
Sahadev S. Chirke (2014)
Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor.
F. Giannese (2013)
Synthesis of Bicyclic N‐Arylmethyl‐Substituted Iminoribitol Derivatives as Selective Nucleoside Hydrolase Inhibitors
M. Berg (2009)
Mannich bases in medicinal chemistry and drug design
G. Roman (2015)
Computational insight into the broad substrate specificity of enzymes that process nucleic acids
S. Lenz (2018)
Nucleoside Analogues: Synthesis and Biological Properties of Azanucleoside Derivatives
D. Hernández (2014)